CADUET
BGP PHARMA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of CADUET in Canada?
A shortage of CADUET 10MG 40MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 29, 2026), but it has not started yet.
Why is CADUET not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will CADUET be available again?
The manufacturer's estimated resolution date is November 10, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-11-10
~36 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02273306
Strength
10MG 40MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
AMLODIPINE ATORVASTATIN
Tier
Unrated
Last Updated
2026-09-29
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.